RB Capital Management LLC Sells 33 Shares of HCA Healthcare, Inc. (NYSE:HCA)

RB Capital Management LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,898 shares of the company’s stock after selling 33 shares during the period. RB Capital Management LLC’s holdings in HCA Healthcare were worth $1,178,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. FMR LLC grew its holdings in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in HCA Healthcare by 2.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after acquiring an additional 41,190 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in HCA Healthcare by 12.0% in the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after acquiring an additional 143,995 shares during the last quarter. Darsana Capital Partners LP boosted its holdings in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after acquiring an additional 400,000 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in HCA Healthcare by 2.7% in the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after acquiring an additional 19,812 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HCA. TD Cowen cut their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. KeyCorp dropped their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Finally, Barclays dropped their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $380.29.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. Insiders own 1.70% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $318.46 on Tuesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12 month low of $255.73 and a 12 month high of $417.14. The stock has a 50 day moving average of $362.09 and a 200-day moving average of $358.91. The company has a market capitalization of $80.67 billion, a P/E ratio of 14.30, a P/E/G ratio of 1.23 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.